217 related articles for article (PubMed ID: 33080840)
1. Impact of Clinical Markers of Nutritional Status and Feeding Jejunostomy Use on Outcomes in Esophageal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy.
Jain R; Shaikh T; Yee JL; Au C; Denlinger CS; Handorf E; Meyer JE; Dotan E
Nutrients; 2020 Oct; 12(10):. PubMed ID: 33080840
[TBL] [Abstract][Full Text] [Related]
2. Routine placement of feeding jejunostomy tube during esophagectomy increases postoperative complications and does not improve postoperative malnutrition.
Koterazawa Y; Oshikiri T; Hasegawa H; Yamamoto M; Kanaji S; Yamashita K; Matsuda T; Nakamura T; Suzuki S; Kakeji Y
Dis Esophagus; 2020 Jan; 33(1):. PubMed ID: 30997494
[TBL] [Abstract][Full Text] [Related]
3. Nutritional optimization during neoadjuvant therapy prior to surgical resection of esophageal cancer-a narrative review.
Huddy JR; Huddy FMS; Markar SR; Tucker O
Dis Esophagus; 2018 Jan; 31(1):1-11. PubMed ID: 29024949
[TBL] [Abstract][Full Text] [Related]
4. Complications of Feeding Jejunostomy Tubes in Patients with Gastroesophageal Cancer.
Choi AH; O'Leary MP; Merchant SJ; Sun V; Chao J; Raz DJ; Kim JY; Kim J
J Gastrointest Surg; 2017 Feb; 21(2):259-265. PubMed ID: 27785689
[TBL] [Abstract][Full Text] [Related]
5. Clinical Benefits of Routine Feeding Jejunostomy Tube Placement in Patients Undergoing Esophagectomy.
Omori A; Tsunoda S; Nishigori T; Hisamori S; Hoshino N; Ikeda A; Obama K
J Gastrointest Surg; 2022 Apr; 26(4):733-741. PubMed ID: 35141836
[TBL] [Abstract][Full Text] [Related]
6. Effect of Extending the Original Eligibility Criteria for the CROSS Neoadjuvant Chemoradiotherapy on Toxicity and Survival in Esophageal Cancer.
de Heer EC; Hulshoff JB; Klerk D; Burgerhof JGM; de Groot DJA; Plukker JTM; Hospers GAP
Ann Surg Oncol; 2017 Jul; 24(7):1811-1820. PubMed ID: 28188501
[TBL] [Abstract][Full Text] [Related]
7. Impact of Early Jejunostomy Tube Feeding on Clinical Outcome and Parameters of Body Composition in Esophageal Cancer Patients Receiving Multimodal Therapy.
Boshier PR; Klevebro F; Schmidt A; Han S; Jenq W; Puccetti F; Seesing MFJ; Baracos VE; Low DE
Ann Surg Oncol; 2022 Sep; 29(9):5689-5697. PubMed ID: 35616747
[TBL] [Abstract][Full Text] [Related]
8. Treatment-related toxicity and outcomes in older versus younger patients with esophageal cancer treated with neoadjuvant chemoradiation.
Jain R; Yee JL; Shaikh T; Au C; Handorf E; Meyer JE; Dotan E
J Geriatr Oncol; 2020 May; 11(4):668-674. PubMed ID: 31257165
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant Therapy for Locally Advanced Esophageal Cancer Should Be Targeted to Tumor Histology.
Stiles BM; Kamel MK; Harrison SW; Rahouma M; Lee B; Nasar A; Port JL; Altorki NK
Ann Thorac Surg; 2019 Jan; 107(1):187-193. PubMed ID: 30278165
[TBL] [Abstract][Full Text] [Related]
10. Benefits of Supplemental Jejunostomy Tube Feeding During Neoadjuvant Therapy in Patients with Locally Advanced, Potentially Resectable Esophageal Cancer.
Dalton BGA; Friedant AJ; Su S; Schatz TAP; Ruth KJ; Scott WJ
J Laparoendosc Adv Surg Tech A; 2017 Dec; 27(12):1279-1283. PubMed ID: 28777676
[TBL] [Abstract][Full Text] [Related]
11. Self-expanding plastic esophageal stents versus jejunostomy tubes for the maintenance of nutrition during neoadjuvant chemoradiation therapy in patients with esophageal cancer: a retrospective study.
Siddiqui AA; Glynn C; Loren D; Kowalski T
Dis Esophagus; 2009; 22(3):216-22. PubMed ID: 19207544
[TBL] [Abstract][Full Text] [Related]
12. Preoperative enteral access is not necessary prior to multimodality treatment of esophageal cancer.
Jenkins TK; Lopez AN; Sarosi GA; Ben-David K; Thomas RM
Surgery; 2018 Apr; 163(4):770-776. PubMed ID: 29198770
[TBL] [Abstract][Full Text] [Related]
13. Impact of Weight Loss on Patients with Locally Advanced Esophageal and Esophagogastric Junction Cancers Treated with Chemoradiotherapy.
Wiwitkeyoonwong J; Jiarpinitnun C; Hiranyatheb P; Ngamphaiboon N
Asian Pac J Cancer Prev; 2021 Dec; 22(12):3847-3855. PubMed ID: 34967563
[TBL] [Abstract][Full Text] [Related]
14. Is the routine placement of a feeding jejunostomy during esophagectomy worthwhile?-a systematic review and meta-analysis.
Shen X; Zhuo ZG; Li G; Alai GH; Song TN; Xu ZJ; Yao P; Lin YD
Ann Palliat Med; 2021 Apr; 10(4):4232-4241. PubMed ID: 33894727
[TBL] [Abstract][Full Text] [Related]
15. Reassessment of the role of enteral tube feedings for patients with esophageal cancer.
Starr B; Davis S; Ayala-Peacock D; Blackstock WA; Levine EA
Am Surg; 2014 Aug; 80(8):752-8. PubMed ID: 25105392
[TBL] [Abstract][Full Text] [Related]
16. Enteral Access is not Required for Esophageal Cancer Patients Undergoing Neoadjuvant Therapy.
Huerter ME; Charles EJ; Downs EA; Hu Y; Lau CL; Isbell JM; McMurry TL; Kozower BD
Ann Thorac Surg; 2016 Sep; 102(3):948-954. PubMed ID: 27209608
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant versus definitive chemoradiotherapy for locally advanced esophageal cancer : Outcomes and patterns of failure.
Haefner MF; Lang K; Verma V; Koerber SA; Uhlmann L; Debus J; Sterzing F
Strahlenther Onkol; 2018 Feb; 194(2):116-124. PubMed ID: 28916906
[TBL] [Abstract][Full Text] [Related]
18. No Survival Difference with Neoadjuvant Chemoradiotherapy Compared with Chemotherapy in Resectable Esophageal and Gastroesophageal Junction Adenocarcinoma: Results from the National Cancer Data Base.
Al-Sukhni E; Gabriel E; Attwood K; Kukar M; Nurkin SJ; Hochwald SN
J Am Coll Surg; 2016 Dec; 223(6):784-792.e1. PubMed ID: 27641320
[TBL] [Abstract][Full Text] [Related]
19. Perioperative chemotherapy versus neoadjuvant chemoradiotherapy for esophageal or GEJ adenocarcinoma: A propensity score-matched analysis comparing toxicity, pathologic outcome, and survival.
Goense L; van der Sluis PC; van Rossum PSN; van der Horst S; Meijer GJ; Haj Mohammad N; van Vulpen M; Mook S; Ruurda JP; van Hillegersberg R
J Surg Oncol; 2017 Jun; 115(7):812-820. PubMed ID: 28267212
[TBL] [Abstract][Full Text] [Related]
20. Pre-therapy laparoscopic feeding jejunostomy is safe and effective in patients undergoing minimally invasive esophagectomy for cancer.
Ben-David K; Kim T; Caban AM; Rossidis G; Rodriguez SS; Hochwald SN
J Gastrointest Surg; 2013 Aug; 17(8):1352-8. PubMed ID: 23709367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
